Novel ferritin nanoparticle vaccine candidate effective against SARS-CoV-2 variants in preclinical trials

By | June 17, 2021
A team of scientists from the United States has recently evaluated the efficacy of a ferritin nanoparticle-formulated, SARS-CoV-2 spike-based vaccine against newly emerged Variants of Concern (VOCs).